Showing results (1041-1050 of 1,631) with videos related to
Sort By:
Pageof 164
ANZ Journal of Surgery|February 20, 2007
Prioritizing patients for prostatectomy: balancing clinical and psychosocial factorsAndrea J Curtis, Rory Wolfe, Colin O H Russell, et al.Surgical Endoscopy|July 18, 2019
3D laparoscopy does not reduce operative duration or errors in day-case laparoscopic cholecystectomy: a randomised controlled trialKatie E Schwab, Nathan J Curtis, Martin B Whyte, et al.Journal of Patient Experience|November 17, 2022
Exploring the Motivational Drivers of Young Adults with Diabetes for Participation in Kidney ResearchP Mohini, M Palaganas, Y Elia, et al.Cancer Prevention Research (Philadelphia, Pa.)|February 4, 2015
Smoking Is Associated with Acute and Chronic Prostatic Inflammation: Results from the REDUCE StudyDaniel M Moreira, J Curtis Nickel, Leah Gerber, et al.Blood|August 3, 2012
Inhibition of apoptosis by BCL2 prevents leukemic transformation of a murine myelodysplastic syndromeChristopher I Slape, Jesslyn Saw, Jeremy B M Jowett, et al.Journal of the American Chemical Society|April 5, 2023
A Cell Type Selective YM155 Prodrug Targets Receptor-Interacting Protein Kinase 2 to Induce Brain Cancer Cell DeathThomas J West, Junfeng Bi, Francisco Martínez-Peña, et al.Transplantation and Cellular Therapy|April 10, 2021
An Immune Recovery-Based Revaccination Protocol for Pediatric Hematopoietic Stem Cell Transplant Recipients: Revaccination Outcomes Following Pediatric HSCTAndrew S Haynes, Donna J Curtis, Kristen Campbell, et al.Pain Reports|June 17, 2025
Efficacy and safety of drug combinations for chronic pelvic pain: a systematic reviewMohammed Mohiuddin, Rex Park, Ursula Wesselmann, et al.Journal of Pharmacological and Toxicological Methods|June 30, 2024
Innovative approaches to cardiovascular safety pharmacology assessmentMichael K Pugsley, Brett R Winters, Yevgeniya E Koshman, et al.Urology|July 19, 2011
Dutasteride improves outcomes of benign prostatic hyperplasia when evaluated for prostate cancer risk reduction: secondary analysis of the REduction by DUtasteride of prostate Cancer Events (REDUCE) trialClaus G Roehrborn, J Curtis Nickel, Gerald L Andriole, et al.Pageof 164